Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger MYND domain-containing protein 10 (ZMYND10) is a cytoplasmic protein that plays a critical role in the assembly and function of motile cilia. It acts as a co-chaperone in a protein complex that assists in the pre-assembly and stabilization of dynein arms—core molecular structures needed for the movement of cilia. Specifically, ZMYND10 interacts with other assembly factors (such as LRRC6, FKBP8, and HSP90) and is essential for axonemal (the ciliary “skeleton”) organization and motility[1][2][3][4][6]. Mutations in ZMYND10 disrupt dynein arm formation, leading to the inherited disorder **primary ciliary dyskinesia (PCD)**, characterized by defective ciliary movement and a spectrum of clinical symptoms including chronic respiratory tract infections and defects in left-right body asymmetry[2][3][5][6]. ZMYND10 is also recognized as a tumor suppressor gene, frequently altered in certain cancers[6]. There are currently no known drug interactions or therapies precisely targeting ZMYND10.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger MYND domain-containing protein 10 (ZMYND10).